Researchers have found that the drug dronabinol — a synthetic version of the psychoactive THC compound in cannabis — helped ...

Outcomes may improve with disease-modifying drugs and lifestyle change if Alzheimer's could be identified earlier.

University of Pittsburgh scientists have independently validated a new blood test platform that can simultaneously measure ...

An Alzheimer’s treatment from idea to market can take up to 20 years. After a long hiatus, the U.S. Food and Drug Administration (FDA) has approved three new drugs to treat Alzheimer’s since June 2021 ...

Loneliness increased the risk for all-cause dementia, Alzheimer’s disease, vascular dementia, and cognitive impairment, ...

Dronabinol is safe and effective for the treatment of Alzheimer disease with agitation (Agit-AD), according to a study ...

While brain shrinkage is known to occur in everyone because of ageing-related cognitive decline, excess brain shrinkage has ...

A new blood test platform can measure more than a hundred biomarkers of Alzheimer's disease at k the same time, and could aid in early diagnosis, a new study finds.

In the six months that the test has been available through Mayo Clinic Laboratories, demand has exceeded expectations, a lab ...

Frontotemporal dementia can be hard to diagnose because while dementia can be part of the illness, it's not a factor in all ...

The brain has a waste-disposal system that clears away junk proteins that contribute to the development of dementia and ...

The NIH is funding a University of Oklahoma study on whether dementia patients' end-of-life care aligns with their wishes.